{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:28:15Z","timestamp":1769272095917,"version":"3.49.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jcin.2023.12.024","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T14:01:08Z","timestamp":1707746468000},"page":"419-421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["What Oral Anticoagulant Is Best After TAVR"],"prefix":"10.1016","volume":"17","author":[{"given":"Jurri\u00ebn M.","family":"ten Berg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dani\u00ebl C.","family":"Overduin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk-Jan","family":"van Ginkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.jcin.2023.12.024_bib1","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.jacc.2023.09.796","article-title":"The mortality burden of untreated aortic stenosis","volume":"82","author":"G\u00e9n\u00e9reux","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2023.12.024_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.680123","article-title":"Comparing trajectory of surgical aortic valve replacement in the early vs. late transcatheter aortic valve replacement era","volume":"8","author":"Elbaz-Greener","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"18","key":"10.1016\/j.jcin.2023.12.024_bib3","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.jcin.2023.12.024_bib4","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.jcin.2023.12.024_bib5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"70","author":"Nishimura","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"36","key":"10.1016\/j.jcin.2023.12.024_bib6","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2023.12.024_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejim.2022.05.002","article-title":"Evolving concepts in the management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation","volume":"101","author":"van Ginkel","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"18","key":"10.1016\/j.jcin.2023.12.024_bib8","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa1915152","article-title":"Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation","volume":"382","author":"Nijenhuis","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.jcin.2023.12.024_bib9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1911425","article-title":"A\u00a0controlled trial of rivaroxaban after transcatheter aortic-valve replacement","volume":"382","author":"Dangas","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"29","key":"10.1016\/j.jcin.2023.12.024_bib10","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1093\/eurheartj\/ehac242","article-title":"Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial","volume":"43","author":"Collet","year":"2022","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.jcin.2023.12.024_bib11","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1056\/NEJMoa2111016","article-title":"Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR","volume":"385","author":"Van Mieghem","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2023.12.024_bib12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.amjcard.2023.06.049","article-title":"Meta-analysis assessing efficacy and safety of vitamin K antagonists versus direct oral anticoagulants for atrial fibrillation after transcatheter aortic valve implantation","volume":"201","author":"Selvaraj","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2023.12.024_bib13","first-page":"279","article-title":"Safety of switching from a vitamin K Antagonist to a non-vitamin K antagonist oral\u00a0anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomized controlled trial","volume":"149","author":"Joosten","year":"2024","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jcin.2023.12.024_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1160\/TH13-02-0150","article-title":"Gastrointestinal bleeding with the new oral anticoagulants--defining the issues and the management strategies","volume":"110","author":"Desai","year":"2013","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.jcin.2023.12.024_bib15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa1505643","article-title":"Von Willebrand factor multimers during transcatheter aortic-valve replacement","volume":"375","author":"Van Belle","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.jcin.2023.12.024_bib16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jcin.2023.11.038","article-title":"Non\u2013vitamin K antagonist versus vitamin K antagonist oral anticoagulant agents after transcatheter aortic valve replacement","volume":"17","author":"Alaour","year":"2024","journal-title":"J Am Coll Cardiol Intv"},{"issue":"18","key":"10.1016\/j.jcin.2023.12.024_bib17","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.jcin.2022.07.014","article-title":"Apixaban and valve thrombosis after transcatheter aortic valve replacement","volume":"15","author":"Gilles","year":"2022","journal-title":"J\u00a0Am Coll Cardiol Intv"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879823016606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879823016606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:18:54Z","timestamp":1761848334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879823016606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1936879823016606"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2023.12.024","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What Oral Anticoagulant Is Best After TAVR","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2023.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2023.11.038","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}